Veterinary Medicine Information website

DRYCLOX-N

Authorised
  • NEOMYCIN SULFATE
  • Cloxacillin hemibenzathine
Download as PDF

Product identification

Medicine name:
DRYCLOX-N
Active substance:
  • NEOMYCIN SULFATE
  • Cloxacillin hemibenzathine
Target species:
  • Cattle (dairy cow at drying-off)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    250.00
    milligram(s)
    /
    1.00
    Syringe
  • Cloxacillin hemibenzathine
    500.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cow at drying-off)
      • Meat and offal
        70
        day
      • Milk
        45
        day
      • Milk
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC26
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Available in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kepro B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Kepro B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1708
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 3/02/2022
Download